Diabetes is a leading killer disease, more so in India. Guidelines to prevent or delay the onset of the illness will benefit the already burdened state healthcare, especially at the monitory level. In our country, it could greatly reduce the expenditure incurred to a middle class diabetic Indian. Click on to the sit to read these guidelines.

Team@CMHF

The National Institute for Health and Clinical Excellence NICE has published new guidance on preventing type 2 diabetes in the general population, and among high-risk groups.

These groups include people of South Asian, African-Caribbean, black African and Chinese descent, and those from a lower socio-economic background, where the incidence of type 2 diabetes is higher than in the general population.

With rising numbers affected by the condition, the incidence of serious complications is also on the rise. These include cardiovascular disease (CVD) and foot problems such as ulcerations and gangrene. Diabetes is also the leading cause of blindness in people of working age in the UK due to retinopathy.

Given that the risk factors for type 2 diabetes are also common to other chronic diseases including CVD and some cancers, the guidance is able to draw on evidence from existing NICE guidance to underpin many of its recommendations for both local and national interventions as part of a comprehensive prevention strategy.

SOURCE: National Institute for Health and Clinical Excellence

Ref: http://www.docguide.com/nice-publishes-new-guidance-preventing-type-2-diabetes?hash=80445d1a&eid=19996&alrhash=2efbb8-880279c42369cc2f8adcb48a6daaf3d2